Views & Analysis Is the NHS ready to use real-world evidence to treat cancer? Is NHS ready to use real-world data to find new therapies and ways to bring drugs to patients?
Views & Analysis ‘Real world’ COPD trial gives GSK a dose of reality Salford Lung Study is a bold experiment, but hasn't fully paid off for GSK.
R&D Allogeneic cell therapy isn’t dead, with Brian Culley Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
